215 related articles for article (PubMed ID: 32718905)
21. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
Medvedeva GF; Kuzmina DO; Nuzhina J; Shtil AA; Dukhinova MS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800829
[TBL] [Abstract][Full Text] [Related]
22. Role of BAG3 in cancer progression: A therapeutic opportunity.
De Marco M; Basile A; Iorio V; Festa M; Falco A; Ranieri B; Pascale M; Sala G; Remondelli P; Capunzo M; Firpo MA; Pezzilli R; Marzullo L; Cavallo P; De Laurenzi V; Turco MC; Rosati A
Semin Cell Dev Biol; 2018 Jun; 78():85-92. PubMed ID: 28864347
[TBL] [Abstract][Full Text] [Related]
23. BAG3 epigenetically regulates GALNT10 expression via WDR5 and facilitates the stem cell-like properties of platin-resistant ovarian cancer cells.
Zhao FY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Liu BQ; Yan J; Li C; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119077. PubMed ID: 34111434
[TBL] [Abstract][Full Text] [Related]
24. miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
Wang Y; Tian Y
Oncol Res; 2018 Jul; 26(6):923-931. PubMed ID: 29295729
[TBL] [Abstract][Full Text] [Related]
25. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Croft A; Yan XG; Jin L; Zhang XD; Jiang CC
Mol Carcinog; 2018 Feb; 57(2):284-294. PubMed ID: 29068469
[TBL] [Abstract][Full Text] [Related]
26. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
27. BAG3: a new therapeutic target of human cancers?
Zhu H; Liu P; Li J
Histol Histopathol; 2012 Mar; 27(3):257-61. PubMed ID: 22237703
[TBL] [Abstract][Full Text] [Related]
28. The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.
DeRosa A; Leftin A
Front Immunol; 2021; 12():614294. PubMed ID: 33986740
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.
Kirk JA; Cheung JY; Feldman AM
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396980
[TBL] [Abstract][Full Text] [Related]
30. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
Front Immunol; 2020; 11():605231. PubMed ID: 33628205
[TBL] [Abstract][Full Text] [Related]
31. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
[TBL] [Abstract][Full Text] [Related]
32. Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy.
Ma Y; Gai Y; Yan J; Li J; Zhang Y
Med Sci Monit; 2016 Mar; 22():977-83. PubMed ID: 27011313
[TBL] [Abstract][Full Text] [Related]
33. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
Janji B; Berchem G; Chouaib S
Front Immunol; 2018; 9():887. PubMed ID: 29922284
[TBL] [Abstract][Full Text] [Related]
34. Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies.
Darvishi B; Majidzadeh-A K; Ghadirian R; Mosayebzadeh M; Farahmand L
Life Sci; 2019 Jan; 217():34-40. PubMed ID: 30472294
[TBL] [Abstract][Full Text] [Related]
35. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.
Chiappetta G; Ammirante M; Basile A; Rosati A; Festa M; Monaco M; Vuttariello E; Pasquinelli R; Arra C; Zerilli M; Todaro M; Stassi G; Pezzullo L; Gentilella A; Tosco A; Pascale M; Marzullo L; Belisario MA; Turco MC; Leone A
J Clin Endocrinol Metab; 2007 Mar; 92(3):1159-63. PubMed ID: 17164298
[TBL] [Abstract][Full Text] [Related]
36. BAG3 Protein Is Over-Expressed in Endometrioid Endometrial Adenocarcinomas.
Esposito V; Baldi C; Zeppa P; Festa M; Guerriero L; d'Avenia M; Chetta M; Zullo F; De Laurenzi V; Turco MC; Rosati A; Guida M
J Cell Physiol; 2017 Feb; 232(2):309-311. PubMed ID: 27414463
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes.
Tahrir FG; Knezevic T; Gupta MK; Gordon J; Cheung JY; Feldman AM; Khalili K
J Cell Physiol; 2017 Apr; 232(4):797-805. PubMed ID: 27381181
[TBL] [Abstract][Full Text] [Related]
38. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
[TBL] [Abstract][Full Text] [Related]
39. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
Leask A
Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
[TBL] [Abstract][Full Text] [Related]
40. At the Crossroads of Apoptosis and Autophagy: Multiple Roles of the Co-Chaperone BAG3 in Stress and Therapy Resistance of Cancer.
Kögel D; Linder B; Brunschweiger A; Chines S; Behl C
Cells; 2020 Feb; 9(3):. PubMed ID: 32121220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
